Neurobiological underpinnings of the estrogen - mood relationship

Current Psychiatry Reviews

Volumn 8, Issue 3, 2012, Pages 247-256

  Wharton, Whitney ^a,b,c   Gleason, Carey E ^a,b,c   Sandra, Olson ^a,b,c   Carlsson, Cynthia M ^a,b,c   Asthana, Sanjay ^a,b,c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

Affect; Cognition; Estrogen therapy; Hormone therapy; Mood; Women's health initiative

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTRONE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

AMYGDALOID NUCLEUS; ARTICLE; COGNITION; DEMENTIA; DEPRESSION; DRUG EFFICACY; ESTROGEN ACTIVITY; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; HORMONE RECEPTOR INTERACTION; HUMAN; MAJOR DEPRESSION; MEDICAL RESEARCH; MENOPAUSE; MOOD; NEUROBIOLOGY; NEUROENDOCRINOLOGY; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; TEMPORAL LOBE; VENOUS THROMBOEMBOLISM;

EID: 84862610631     PISSN: 15734005     EISSN: 18756441     Source Type: Journal    
DOI: 10.2174/157340012800792957     Document Type: Article

References (136)

1. Romanoski AJ, Folstein MF, Nestadt G, Chahal R, Merchant A, Brown CH, et al. The epidemiology of psychiatrist-ascertained depression and DSM-III depressive disorders. Results from the Eastern Baltimore Mental Health Survey Clinical Reappraisal. Psychological medicine. 1992 Aug;22(3):629-55.
2. Beekman AT, Geerlings SW, Deeg DJ, Smit JH, Schoevers RS, de Beurs E, et al. The natural history of late-life depression: a 6-year prospective study in the community. Archives of general psychiatry. 2002 Jul;59(7):605-11.
3. Judd LL, Paulus MP, Wells KB, Rapaport MH. Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population. The American journal of psychiatry. 1996 Nov;153(11):1411-7.
4. Judd LL, Akiskal HS. Delineating the longitudinal structure of depressive illness: beyond clinical subtypes and duration thresholds. Pharmacopsychiatry. 2000 Jan;33(1):3-7.
5. Rapaport MH, Judd LL. Minor depressive disorder and subsyndromal depressive symptoms: functional impairment and response to treatment. J Affect Disord. 1998 Mar;48(2-3):227-32.
6. Angst J, Gamma A, Gastpar M, Lepine JP, Mendlewicz J, Tylee A. Gender differences in depression. Epidemiological findings from the European DEPRES I and II studies. European archives of psychiatry and clinical neuroscience. 2002 Oct;252(5):201-9.
7. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, et al. Cross-national epidemiology of major depression and bipolar disorder. Jama. 1996 Jul 24-31;276(4):293-9.
8. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB. Sex and depression in the National Comorbidity Survey I: Lifetime prevalence, chronicity and recurrence. Journal of Affective Disorders. 1993;29(2-3):85-96.
9. Halbreich U, Kahn LS. Role of estrogen in the aetiology and treatment of mood disorders. CNS drugs. 2001;15(10):797-817.
10. Hardy R, Kuh D. Change in psychological and vasomotor symptom reporting during the menopause. Soc Sci Med. 2002 Dec; 55(11):1975-88.
11. Matthews KA. Myths and realities of the menopause. Psychosomatic medicine. 1992 Jan-Feb;54(1):1-9.
12. Woods NF, Mariella A, Mitchell ES. Patterns of depressed mood across the menopausal transition: approaches to studying patterns in longitudinal data. Acta Obstet Gynecol Scand. 2002 Jul;81(7): 623-32.
13. Paoletti AM, Floris S, Mannias M, Orru M, Crippa D, Orlandi R, et al. Evidence that cyproterone acetate improves psychological symptoms and enhances the activity of the dopaminergic system in postmenopause. The Journal of clinical endocrinology and metabolism. 2001 Feb;86(2):608-12.
14. Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, et al. Estrogen replacement in perimenopause-related depression: a preliminary report. American journal of obstetrics and gynecology. 2000 Aug;183(2):414-20.
15. Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Archives of general psychiatry. 2001 Jun;58(6):529-34.
16. Albertazzi P, Natale V, Barbolini C, Teglio L, Di Micco R. The effect of tibolone versus continuous combined norethisterone acetate and oestradiol on memory, libido and mood of postmenopausal women: a pilot study. Maturitas. 2000;Oct 31; 36(3): 223-9.
17. Goodnick PJ, Chaudry T, Artadi J, Arcey S. Women's issues in mood disorders. Expert opinion on pharmacotherapy. 2000 Jul;1(5):903-16.
18. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. Jama. 2002 Jul 17;288(3):321-33.
19. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. Jama. 2004 Jun 23;291(24):2947-58.
20. Resnick SM, Maki PM, Rapp SR, Espeland MA, Brunner R, Coker LH, et al. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. The Journal of clinical endocrinology and metabolism. 2006 May;91(5):1802-10.
21. Reynolds RF, Walker AM, Obermeyer CM, Rahman O, Guilbert D. Discontinuation of postmenopausal hormone therapy in a Massachusetts HMO. Journal of clinical epidemiology. 2001 Oct;54(10):1056-64.
22. McIntyre RS, Konarski JZ, Grigoriadis S, Fan NC, Mancini DA, Fulton KA, et al. Hormone replacement therapy and antidepressant prescription patterns: a reciprocal relationship. Cmaj. 2005 Jan 4;172(1):57-9.
23. Diener E, Emmons RA, Larsen RJ, Griffin S. The Satisfaction With Life Scale. Journal of personality assessment. 1985 Feb;49(1):71-5.
24. Oinonen KA, Mazmanian D. To what extent do oral contraceptives influence mood and affect? Journal of Affective Disorders. 2002;70(3):229-40.
25. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC. Production and actions of estrogens. The New England journal of medicine. 2002 Jan 31;346(5):340-52.
26. Gruber C, Tschugguel W, Schneeberger C, Huber J. Production and actions of estrogens. N Engl J Med. 2002;346:340-52.
27. Michaud DS, Manson JE, Spiegelman D, Barbieri RL, Sepkovic DW, Bradlow HL, et al. Reproducibility of plasma and urinary sex hormone levels in premenopausal women over a one-year period. Cancer Epidemiol Biomarkers Prev. 1999 Dec;8(12):1059-64.
28. Romani W, Patrie J, Curl LA, Flaws JA. The correlations between estradiol, estrone, estriol, progesterone, and sex hormone-binding globulin and anterior cruciate ligament stiffness in healthy, active females. J Womens Health (Larchmt). 2003 Apr;12(3):287-98.
29. Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. Journal of National Cancer Institute. 1998 Sep 2;90(17):1292-9.
30. Rannevik G, Jeppsson S, Johnell O, Bjerre B, Laurell-Borulf Y, Svanberg L. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas. 1995 Feb;21(2):103-13.
31. Blazer DG, Kessler RC, McGonagle KA, Swartz MS. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry. 1994 Jul;151(7):979-86.
32. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-IIIR psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994 Jan; 51(1):8-19.
33. Pisani G, Facioni L, Fiorani F, Pisani G. [Psychosexual problems in menopause]. Minerva Ginecol. 1998 Mar;50(3):77-81.
34. Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H. Hormonal evidence for altered responsiveness to social stress in major depression. Neuropsychopharmacology. 2000 Oct;23(4): 411-8.
35. Dalton K. Menstruation and acute psychiatric illnesses. British medical journal. 1959 Jan 17;1(5115):148-9.
36. Avis NE, Brambilla D, McKinlay SM, Vass K. A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women's Health Study. Ann Epidemiol. 1994 May;4(3):214-20.
37. Kessler RC, McGonagle KA, Nelson CB, Hughes M, Swartz M, Blazer DG. Sex and depression in the National Comorbidity Survey. II: Cohort effects. J Affect Disord. 1994 Jan;30(1):15-26.
38. Richards M, Rubinow DR, Daly RC, Schmidt PJ. Premenstrual symptoms and perimenopausal depression. Am J Psychiatry. 2006 Jan;163(1):133-7.
39. Dennerstein L, Guthrie JR, Clark M, Lehert P, Henderson VW. A population-based study of depressed mood in middle-aged, Australian-born women. Menopause. 2004 Sep-Oct;11(5):563-8.
40. Chung-Park M. Anxiety attacks following surgical menopause: a case report. Holist Nurs Pract. 2005 Sep-Oct;19(5):236-40.
41. Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, et al. Estrogen replacement in perimenopause-related depression: A preliminary report. American journal of obstetrics and gynecology. 2000;183(2):414-20.
42. Morrison MF, Kallan MJ, Ten Have T, Katz I, Tweedy K, Battistini M. Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry. 2004 Feb 15;55(4):406-12.
43. Schmidt PJ. Mood, depression, and reproductive hormones in the menopausal transition. Am J Med. 2005 Dec 19;118(12 Suppl 2):54-8.
44. Phan KL, Wager T, Taylor SF, Liberzon I. Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. NeuroImage. 2002 Jun;16(2):331-48.
45. Ostlund H, Keller E, Hurd YL. Estrogen receptor gene expression in relation to neuropsychiatric disorders. Annals of the New York Academy of Sciences. 2003 Dec;1007:54-63.
46. Merchenthaler I, Lane MV, Numan S, Dellovade TL. Distribution of estrogen receptor alpha and beta in the mouse central nervous system: in vivo autoradiographic and immunocytochemical analyses. The Journal of comparative neurology. 2004 May 24; 473(2):270-91.
47. Mitra SW, Hoskin E, Yudkovitz J, Pear L, Wilkinson HA, Hayashi S, et al. Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha. Endocrinology. 2003 May;144(5):2055-67.
48. Shughrue P, Scrimo P, Lane M, Askew R, Merchenthaler I. The distribution of estrogen receptor-beta mRNA in forebrain regions of the estrogen receptor-alpha knockout mouse. Endocrinology. 1997 Dec;138(12):5649-52.
49. Shughrue PJ, Merchenthaler I. Distribution of estrogen receptor beta immunoreactivity in the rat central nervous system. The Journal of comparative neurology. 2001 Jul 16;436(1):64-81.
50. Rasia-Filho AA, Fabian C, Rigoti KM, Achaval M. Influence of sex, estrous cycle and motherhood on dendritic spine density in the rat medial amygdala revealed by the Golgi method. Neuroscience. 2004;126(4):839-47.
51. Nishizuka M, Arai Y. Synapse formation in response to estrogen in the medial amygdala developing in the eye. Proceedings of the National Academy of Sciences of the United States of America. 1982 Nov;79(22):7024-6.
52. Frye CA, Walf AA. Estrogen and/or progesterone administered systemically or to the amygdala can have anxiety-, fear-, and painreducing effects in ovariectomized rats. Behavioral neuroscience. 2004 Apr;118(2):306-13.
53. Campbell S, Marriott M, Nahmias C, MacQueen GM. Lower hippocampal volume in patients suffering from depression: a metaanalysis. The American journal of psychiatry. 2004 Apr;161(4): 598-607.
54. Videbech P, Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. The American journal of psychiatry. 2004 Nov;161(11):1957-66.
55. Duman RS, Nakagawa S, Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology. 2001 Dec;25(6):836-44.
56. Protopopescu X, Butler T, Pan H, Root J, Altemus M, Polanecsky M, et al. Hippocampal structural changes across the menstrual cycle. Hippocampus. 2008;18(10):985-8.
57. Brinton RD. Estrogen-induced plasticity from cells to circuits: predictions for cognitive function. Trends in pharmacological sciences. 2009 Apr;30(4):212-22.
58. Walf AA, Paris JJ, Frye CA. Chronic estradiol replacement to aged female rats reduces anxiety-like and depression-like behavior and enhances cognitive performance. Psychoneuroendocrinology. 2009 Feb 10.
59. Eberling JL, Wu C, Haan MN, Mungas D, Buonocore M, Jagust WJ. Preliminary evidence that estrogen protects against age-related hippocampal atrophy. Neurobiol Aging. 2003 Sep;24(5):725-32.
60. Lord C, Buss C, Lupien SJ, Pruessner JC. Hippocampal volumes are larger in postmenopausal women using estrogen therapy compared to past users, never users and men: A possible window of opportunity effect. Neurobiology of Aging. 2008;29(1):95-101.
61. PM. Estrogen effects on the hippocampus and frontal lobes. International journal of fertility and women's medicine. 2005 Mar- Apr;50(2):67-71.
62. Wharton W, Fitzgerald, Dowling, M.A., Carlsson, C. M., Asthana, S., Johnson, S.C., Gleason CE. Effects of Hormone Therapy Duration on Functional MRI Activation. Graylyn Conference in Women's Cognitive Health;; Winston-Salem, NC 2007.
63. Halbreich U. Role of estrogen in postmenopausal depression. Neurology. 1997 May;48(5 Suppl 7):S16-9.
64. McEwen BS. Invited review: Estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol. 2001 Dec;91(6):2785-801.
65. Bloch M, Rubinow DR, Schmidt PJ, Lotsikas A, Chrousos GP, Cizza G. Cortisol response to ovine corticotropin-releasing hormone in a model of pregnancy and parturition in euthymic women with and without a history of postpartum depression. The Journal of clinical endocrinology and metabolism. 2005 Feb; 90(2):695-9.
66. Gibbs RB, Gabor R. Estrogen and cognition: applying preclinical findings to clinical perspectives. J Neurosci Res. 2003 Dec 1;74(5):637-43.
67. Lerer B, Gelfin Y, Gorfine M, Allolio B, Lesch KP, Newman ME. 5-HT1A receptor function in normal subjects on clinical doses of fluoxetine: blunted temperature and hormone responses to ipsapirone challenge. Neuropsychopharmacology. 1999 Jun;20(6): 628-39.
68. Miettinen RA, Kalesnykas G, Koivisto EH. Estimation of the total number of cholinergic neurons containing estrogen receptor-alpha in the rat basal forebrain. J Histochem Cytochem. 2002 Jul;50(7): 891-902.
69. Toran-Allerand CD, Miranda RC, Bentham WD, Sohrabji F, Brown TJ, Hochberg RB, et al. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proceedings of the National Academy of Sciences of the United States of America. 1992 May 15;89(10): 4668-72.
70. Bennett KM, Hoelting C, Martin CP, Stoll J. Estrogen effects on high-affinity choline uptake in primary cultures of rat basal forebrain. Neurochemical research. 2009 Feb;34(2):205-14.
71. van Amelsvoort T, Compton J, Murphy D. In vivo assessment of the effects of estrogen on human brain. Trends Endocrinol Metab. 2001 Aug;12(6):273-6.
72. Yaffe K. Estrogens, selective estrogen receptor modulators, and dementia: what is the evidence? Ann N Y Acad Sci. 2001 Dec;949:215-22.
73. Matsuda Y, Hirano H, Watanabe Y. Effects of estrogen on acetylcholine release in frontal cortex of female rats: involvement of serotonergic neuronal systems. Brain Res. 2002 May 24;937(1- 2):58-65.
74. Osterlund MK, Halldin C, Hurd YL. Effects of chronic 17betaestradiol treatment on the serotonin 5-HT(1A) receptor mRNA and binding levels in the rat brain. Synapse (New York, NY. 2000 Jan;35(1):39-44.
75. Mossner R, Daniel S, Albert D, Heils A, Okladnova O, Schmitt A, et al. Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF). Neurochemistry international. 2000 Mar;36(3):197-202.
76. Mossner R, Schmitt A, Syagailo Y, Gerlach M, Riederer P, Lesch KP. The serotonin transporter in Alzheimer's and Parkinson's disease. Journal of neural transmission. 2000(60):345-50.
77. Cyr M, Landry M, Di Paolo T. Modulation by estrogen-receptor directed drugs of 5-hydroxytryptamine-2A receptors in rat brain. Neuropsychopharmacology. 2000 Jul;23(1):69-78.
78. Soares CN, Poitras JR, Prouty J, Alexander AB, Shifren JL, Cohen LS. Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms. The Journal of clinical psychiatry. 2003 Apr;64(4):473-9.
79. Thase ME, Entsuah R, Cantillon M, Kornstein SG. Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions. Journal of women's health (2002). 2005 Sep;14(7): 609-16.
80. Joffe H, Soares CN, Petrillo LF, Viguera AC, Somley BL, Koch JK, et al. Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetine. The Journal of clinical psychiatry. 2007 Jun;68(6): 943-50.
81. Epperson SA, Brunton LL, Ramirez-Sanchez I, Villarreal FJ. Adenosine receptors and second messenger signaling pathways in rat cardiac fibroblasts. American journal of physiology. 2009 Feb 25.
82. Halbreich U, Rojansky N, Palter S, Tworek H, Hissin P, Wang K. Estrogen augments serotonergic activity in postmenopausal women. Biological psychiatry. 1995 Apr 1;37(7):434-41.
83. McEwen BS, Alves SE, Bulloch K, Weiland NG. Ovarian steroids and the brain: implications for cognition and aging. Neurology. 1997 May;48(5 Suppl 7):S8-15.
84. Matsumoto A, Arai Y, Osanai M. Estrogen stimulates neuronal plasticity in the deafferented hypothalamic arcuate nucleus in aged female rats. Neuroscience research. 1985 Jun;2(5):412-8.
85. Dickinson SL, Curzon G. 5-Hydroxytryptamine-mediated behaviour in male and female rats. Neuropharmacology. 1986 Jul;25(7):771-6.
86. Chakravorty SG, Halbreich U. The influence of estrogen on monoamine oxidase activity. Psychopharmacology bulletin. 1997;33(2):229-33.
87. Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 1999 Aug;38(8):1083-152.
88. Krezel W, Dupont S, Krust A, Chambon P, Chapman PF. Increased anxiety and synaptic plasticity in estrogen receptor beta -deficient mice. Proceedings of the National Academy of Sciences of the United States of America. 2001 Oct 9;98(21):12278-82.
89. Sweet RA, Hamilton RL, Healy MT, Wisniewski SR, Henteleff R, Pollock BG, et al. Alterations of striatal dopamine receptor binding in Alzheimer disease are associated with Lewy body pathology and antemortem psychosis. Arch Neurol. 2001 Mar; 58(3): 466-72.
90. Sawada H, Shimohama S. Neuroprotective effects of estradiol in mesencephalic dopaminergic neurons. Neurosci Biobehav Rev. 2000 Jan;24(1):143-7.
91. Sawada H, Ibi M, Kihara T, Urushitani M, Honda K, Nakanishi M, et al. Mechanisms of antiapoptotic effects of estrogens in nigral dopaminergic neurons. Faseb J. 2000 Jun;14(9):1202-14.
92. Barbanti P, Fabbrini G, Ricci A, Bruno G, Cerbo R, Bronzetti E, et al. Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer's disease. Mech Ageing Dev. 2000 Dec 1;120(1-3):65-75.
93. Menozzi R, Cagnacci A, Zanni AL, Bondi M, Volpe A, Del Rio G. Sympathoadrenal response of postmenopausal women prior and during prolonged administration of estradiol. Maturitas. 2000 Mar 31;34(3):275-81.
94. Komesaroff PA, Esler MD, Sudhir K. Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women. J Clin Endocrinol Metab. 1999 Feb;84(2):606-10.
95. Kim YJ, Hur EM, Park TJ, Kim KT. Nongenomic inhibition of catecholamine secretion by 17beta-estradiol in PC12 cells. J Neurochem. 2000 Jun;74(6):2490-6.
96. Dayas CV, Xu Y, Buller KM, Day TA. Effects of chronic oestrogen replacement on stress-induced activation of hypothalamic-pituitaryadrenal axis control pathways. J Neuroendocrinol. 2000 Aug;12(8): 784-94.
97. Nakazawa K, Ohno Y. Modulation by estrogens and xenoestrogens of recombinant human neuronal nicotinic receptors. Eur J Pharmacol. 2001 Nov 2;430(2-3):175-83.
98. Daniel JM, Hulst JL, Lee CD. Role of hippocampal M2 muscarinic receptors in the estrogen-induced enhancement of working memory. Neuroscience. 2005;132(1):57-64.
99. Kritzer MF, Kohama SG. Ovarian hormones differentially influence immunoreactivity for dopamine beta- hydroxylase, choline acetyltransferase, and serotonin in the dorsolateral prefrontal cortex of adult rhesus monkeys. J Comp Neurol. 1999 Jul 5; 409(3):438-51.
100. Walf AA, Paris JJ, Frye CA. Chronic estradiol replacement to aged female rats reduces anxiety-like and depression-like behavior and enhances cognitive performance. Psychoneuroendocrinology. In Press, Corrected Proof.
101. Galea LA, Wide JK, Barr AM. Estradiol alleviates depressive-like symptoms in a novel animal model of post-partum depression. Behavioural brain research. 2001 Jul;122(1):1-9.
102. Almeida OP, Lautenschlager NT, Vasikaran S, Leedman P, Gelavis A, Flicker L. A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: Effect on mood, cognition and quality of life. Neurobiology of Aging. 2006;27(1):141-9.
103. Palinkas LA, Barrett-Connor E. Estrogen use and depressive symptoms in postmenopausal women. Obstetrics and gynecology. 1992 Jul;80(1):30-6.
104. Whooley MA, Grady D, Cauley JA. Postmenopausal estrogen therapy and depressive symptoms in older women. Journal of general internal medicine. 2000 Aug;15(8):535-41.
105. Maartens LW, Knottnerus JA, Pop VJ. Menopausal transition and increased depressive symptomatology: a community based prospective study. Maturitas. 2002 Jul 25;42(3):195-200.
106. Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Archives of general psychiatry. 2004 Jan;61(1):62-70.
107. Bromberger JT, Matthews KA, Schott LL, Brockwell S, Avis NE, Kravitz HM, et al. Depressive symptoms during the menopausal transition: the Study of Women's Health Across the Nation (SWAN). J Affect Disord. 2007 Nov;103(1-3):267-72.
108. Woods NF, Smith-DiJulio K, Percival DB, Tao EY, Mariella A, Mitchell S. Depressed mood during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause (New York, NY. 2008 Mar- Apr;15(2):223-32.
109. Kaufert PA, Gilbert P, Tate R. The Manitoba Project: a reexamination of the link between menopause and depression. Maturitas. 1992 Jan;14(2):143-55.
110. Schmidt PJ, Haq N, Rubinow DR. A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. The American journal of psychiatry. 2004 Dec;161(12):2238-44.
111. Frey BN, Lord C, Soares CN. Depression during menopausal transition: a review of treatment strategies and pathophysiological correlates. Menopause international. 2008 Sep;14(3):123-8.
112. Klaiber EL, Broverman DM, Vogel W, Kobayashi Y. Estrogen therapy for severe persistent depressions in women. Archives of general psychiatry. 1979 May;36(5):550-4.
113. Saletu B, Brandstatter N, Metka M, Stamenkovic M, Anderer P, Semlitsch HV, et al. Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression. Psychopharmacology. 1995 Dec;122(4):321-9.
114. Montgomery JC, Appleby L, Brincat M, Versi E, Tapp A, Fenwick PB, et al. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet. 1987 Feb 7;1(8528):297-9.
115. Strickler RC, Borth R, Cecutti A, Cookson BA, Harper JA, Potvin R, et al. The role of oestrogen replacement in the climacteric syndrome. Psychological medicine. 1977 Nov;7(4):631-9.
116. Coope J. Is oestrogen therapy effective in the treatment of menopausal depression? The Journal of the Royal College of General Practitioners. 1981 Mar;31(224):134-40.
117. Halbreich U. Gonadal hormones, reproductive age, and women with depression. Archives of general psychiatry. 2000 Dec;57(12):1163-4.
118. Gleason CE, Carlsson CM, Johnson S, Atwood C, Asthana S. Clinical pharmacology and differential cognitive efficacy of estrogen preparations. Annals of the New York Academy of Sciences. 2005 Jun;1052:93-115.
119. Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW. Transdermal oestrogen for treatment of severe postnatal depression. Lancet. 1996 Apr 6;347(9006):930-3.
120. Smith RN, Studd JW, Zamblera D, Holland EF. A randomised comparison over 8 months of 100 micrograms and 200 micrograms twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome. British journal of obstetrics and gynaecology. 1995 Jun;102(6):475-84.
121. Schmidt PJ. Mood, depression, and reproductive hormones in the menopausal transition. The American Journal of Medicine. 2005;118(12, Supplement 2):54-8.
122. Pruis TA, Roalf DR, Janowsky JS. Hormone therapy does not modify emotion-induced brain activity in older women. Hormones and behavior. 2009 Nov;56(5):539-47.
123. Berent-Spillson A, Persad CC, Love T, Tkaczyk A, Wang H, Reame NK, et al. Early menopausal hormone use influences brain regions used for visual working memory. Menopause (New York, NY. Jul;17(4):692-9.
124. Girdler SS, O'Briant C, Steege J, Grewen K, Light KC. A comparison of the effect of estrogen with or without progesterone on mood and physical symptoms in postmenopausal women. Journal of women's health & gender-based medicine. 1999 Jun;8(5):637-46.
125. Sherwin BB. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. The Journal of clinical endocrinology and metabolism. 1991 Feb;72(2):336-43.
126. Bjorn I, Bixo M, Nojd KS, Collberg P, Nyberg S, Sundstrom-Poromaa I, et al. The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy. Gynecol Endocrinol. 2002 Feb;16(1):1-8.
127. Fitzpatrick LA, Pace C, Wiita B. Comparison of regimens containing oral micronized progesterone or medroxyprogesterone acetate on quality of life in postmenopausal women: a crosssectional survey. Journal of women's health & gender-based medicine. 2000 May;9(4):381-7.
128. Prior JC, Alojado N, McKay DW, Vigna YM. No adverse effects of medroxyprogesterone treatment without estrogen in postmenopausal women: double-blind, placebo-controlled, crossover trial. Obstetrics and gynecology. 1994 Jan;83(1):24-8.
129. Magos AL, Brewster E, Singh R, O'Dowd T, Brincat M, Studd JW. The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome. British journal of obstetrics and gynaecology. 1986 Dec;93(12):1290-6.
130. Galea LA, Lee TT, Kostaras X, Sidhu JA, Barr AM. High levels of estradiol impair spatial performance in the Morris water maze and increase 'depressive-like' behaviors in the female meadow vole. Physiology & behavior. 2002 Nov;77(2-3):217-25.
131. Okada M, Hayashi N, Kometani M, Nakao K, Inukai T. Influences of ovariectomy and continuous replacement of 17beta-estradiol on the tail skin temperature and behavior in the forced swimming test in rats. Japanese journal of pharmacology. 1997 Jan;73(1):93-6.
132. Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR. Effects of gonadal steroids in women with a history of postpartum depression. The American journal of psychiatry. 2000 Jun;157(6):924-30.
133. Solomon MB, Herman JP. Sex differences in psychopathology: Of gonads, adrenals and mental illness. Physiology & behavior. 2009 Mar 9.
134. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Archives of general psychiatry. 2006 Apr;63(4):375-82.
135. Felthous AR, Robinson DB. Oral contraceptive medication in prevention of psychotic exacerbations associated with phases of the menstrual cycle. Journal of preventive psychiatry. 1981;1(1):5-14.
136. Wharton W, Hirshman E, Merritt P, Doyle L, Paris S, Gleason C. Oral contraceptives and androgenicity: influences on visuospatial task performance in younger individuals. Experimental and clinical psychopharmacology. 2008 Apr;16(2):156-64